Prostatic carcinoma. Changing concepts of therapy
Mebust, W.K.; Foret, J.D.; Valk, W.L.
Journal of the Kansas Medical Society 72(3): 124-125
1971
ISSN/ISBN: 0022-8699 PMID: 5545168 Document Number: 43753
Document emailed within 1 workday
Related Documents
Kumamoto, Y.; Tsukamoto, T.; Umehara, T.; Harada, M.; Shimazaki, J.; Fuse, H.; Oshima, H.; Takeuchi, H.; Yoshida, O.; Okada, K. 1990: Clinical studies on endocrine therapy of prostatic carcinoma (3): Histopathological features of prostatic carcinoma and its prognosis Hinyokika Kiyo. Acta Urologica Japonica 36(3): 295-305Strohmenger, P. 1980: Prostatic adenoma--prostatic carcinoma. Questions from general practice. II. Therapy Zfa. Zeitschrift für Allgemeinmedizin 56(28): 1793-1797
Wright, J.C. 1970: Chemotherapy. Changing concepts in therapy Minnesota Medicine 53(4): 373-377
Graber, H. 1990: Rational antibiotic therapy: new drugs, changing concepts Therapia Hungarica 38(3): 99-105
Bogdanowicz, J.F.; Bentvelsen, F.M.; Oosterom, R.; Schroeder, F.H. 1991: Evaluation of prostate-specific antigen and prostatic acid phosphatase in untreated prostatic carcinoma and benign prostatic hyperplasia Scandinavian Journal of Urology and Nephrology. Supplementum 138: 97-103
Vahlensieck, W.; Tümmers, H.; Tschischak, D. 1974: Diagnosis and therapy of prostatic carcinoma Fortschritte der Medizin 92(30): 1195-1198
Klosterhalfen, H. 1977: Hormone therapy of prostatic carcinoma Deutsche Medizinische Wochenschrift 102(25): 947
Studer, U.E.; Altwein, J.; Bartsch, G. 1991: The potential hormonal therapy of prostatic carcinoma Der Urologe. Ausg. a 30(5): 310-316
Reddy, E.K.; Mansfield, C.M. 1982: Prostatic carcinoma. External radiation therapy Journal of the Kansas Medical Society 83(10): 479-483
Studer, U.E. 1995: Advanced prostatic carcinoma--which hormone therapy when? Der Urologe. Ausg. a 34(5): 361-366
Schmid, H.P. 1995: Possibilities in drug therapy in prostatic carcinoma Therapeutische Umschau. Revue Therapeutique 52(6): 418-422
Studer, U.E.; Münch, D. 1990: Hormonal therapy (medical orchiectomy) in prostatic carcinoma Schweizerische Medizinische Wochenschrift 120(24): 881-887
Weinberg, D.S.; Weidner, N. 1993: Concordance of DNA content between prostatic intraepithelial neoplasia and concomitant invasive carcinoma. Evidence that prostatic intraepithelial neoplasia is a precursor of invasive prostatic carcinoma Archives of Pathology and Laboratory Medicine 117(11): 1132-1137
Bösing, N.M.; Heise, J.W.; Röher, H.D. 2000: Utilization of multimodal therapy concepts in stomach carcinoma in Germany Zentralblatt für Chirurgie 125(4): 341-347
Ferraris, V.; Pacilli, N.; Bottero, G.; Novella, V.; Pisano, P.F.; Buffa, G. 1994: Treatment of prostatic carcinoma in clinical stage C. Comparison between radiotherapy plus hormonal therapy after progression and immediate hormonal therapy Minerva Urologica e Nefrologica 46(2): 123-128
Ebert, T.; Bendhack, M.L. 1997: Prostatic carcinoma--diagnosis, hormone therapy, radio- and chemotherapy Der Urologe. Ausg. a 36(6): 570-577
Leewansangtong, S.; Soontrapa, S. 1999: Hormonal ablation therapy for metastatic prostatic carcinoma: a review Journal of the Medical Association of Thailand 82(2): 192-205
Lorusso, A.; Curatolo, C.; Giocoli Nacci, G.; Ludovico, G.M.; Cirillo Limitone, D.A.; Marucco, E.C.; Pagliarulo, A. 1996: Role of expectant therapy in prostatic carcinoma of low grade and staging Archivio Italiano di Urologia Andrologia: Organo Ufficiale di Societa Italiana di Ecografia Urologica e Nefrologica 68(5 Suppl): 155-157
Vorreuther, R.; Klotz, T.; Engelking, R. 1992: Clodronate in the palliative therapy of bone-metastasized prostatic carcinoma Der Urologe. Ausg. a 31(2): 63-66
Kumamoto, Y.; Tsukamoto, T.; Umehara, T.; Shimazaki, J.; Fuse, H.; Ohshima, H.; Takeuchi, H.; Yoshida, O.; Okada, K.; Saito, Y. 1991: Clinical studies on endocrine therapy for prostatic carcinoma (4): Initial response to endocrine therapy and prognosis Hinyokika Kiyo. Acta Urologica Japonica 37(11): 1505-1510